Literature DB >> 19574307

The modular architecture of meningococcal factor H-binding protein.

Peter T Beernink1, Dan M Granoff1.   

Abstract

Meningococcal factor H binding protein (fHbp) is a promising vaccine antigen that binds the human complement downregulatory molecule factor H (fH), and this binding enhances the survival of the organism in serum. Based on sequence variability of the entire protein, fHbp has been divided into three variant groups or two subfamilies. Here, we present evidence based on phylogenetic analysis of 70 unique fHbp amino acid sequences that the molecular architecture is modular. From sequences of natural chimeras we identified blocks of two to five invariant residues that flanked five modular variable segments. Although overall, 46 % of the fHbp amino acids were invariant, based on a crystal structure, the invariant blocks that flanked the modular variable segments clustered on the membrane surface containing the amino-terminal lipid anchor, while the remaining invariant residues were located throughout the protein. Each of the five modular variable segments could be classified into one of two types, designated alpha or beta, based on homology with segments encoded by variant 1 or 3 fHbp genes, respectively. Forty of the fHbps (57 %) comprised only alpha (n=33) or beta (n=7) type segments. The remaining 30 proteins (43 %) were chimeras and could be classified into one of four modular groups. These included all 15 proteins assigned to the previously described variant 2 in subfamily A. The modular segments of one chimeric modular group had 96 % amino acid identity with those of fHbp orthologs in Neisseria gonorrhoeae. Collectively, the data suggest that recombination between Neisseria meningitidis and N. gonorrhoeae progenitors generated a family of modular, antigenically diverse meningococcal fHbps.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19574307      PMCID: PMC2859308          DOI: 10.1099/mic.0.029876-0

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  32 in total

1.  Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis.

Authors:  J Castresana
Journal:  Mol Biol Evol       Date:  2000-04       Impact factor: 16.240

2.  Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine.

Authors:  Peter T Beernink; Jo Anne Welsch; Lee H Harrison; Arunas Leipus; Sheldon L Kaplan; Dan M Granoff
Journal:  J Infect Dis       Date:  2007-04-05       Impact factor: 5.226

3.  Epitope mapping of a bactericidal monoclonal antibody against the factor H binding protein of Neisseria meningitidis.

Authors:  Maria Scarselli; Francesca Cantini; Laura Santini; Daniele Veggi; Sara Dragonetti; Claudio Donati; Silvana Savino; Marzia M Giuliani; Maurizio Comanducci; Federica Di Marcello; Giacomo Romagnoli; Mariagrazia Pizza; Lucia Banci; Rino Rappuoli
Journal:  J Mol Biol       Date:  2008-12-11       Impact factor: 5.469

4.  Relative contributions of recombination and mutation to the diversification of the opa gene repertoire of Neisseria gonorrhoeae.

Authors:  Nicole Bilek; Catherine A Ison; Brian G Spratt
Journal:  J Bacteriol       Date:  2008-12-29       Impact factor: 3.490

5.  Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen.

Authors:  Jo Anne Welsch; Sanjay Ram; Oliver Koeberling; Dan M Granoff
Journal:  J Infect Dis       Date:  2008-04-01       Impact factor: 5.226

6.  Clustal W and Clustal X version 2.0.

Authors:  M A Larkin; G Blackshields; N P Brown; R Chenna; P A McGettigan; H McWilliam; F Valentin; I M Wallace; A Wilm; R Lopez; J D Thompson; T J Gibson; D G Higgins
Journal:  Bioinformatics       Date:  2007-09-10       Impact factor: 6.937

7.  Variable sequences in a mosaic-like domain of meningococcal tbp2 encode immunoreactive epitopes.

Authors:  B Rokbi; G Maitre-Wilmotte; V Mazarin; L Fourrichon; L Lissolo; M J Quentin-Millet
Journal:  FEMS Microbiol Lett       Date:  1995-10-15       Impact factor: 2.742

8.  Vaccine potential of the Neisseria meningitidis 2086 lipoprotein.

Authors:  Leah D Fletcher; Liesel Bernfield; Vicki Barniak; John E Farley; Alan Howell; Melissa Knauf; Peggy Ooi; Robert P Smith; Paige Weise; Mike Wetherell; Xiaoling Xie; Robert Zagursky; Ying Zhang; Gary W Zlotnick
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

9.  Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa.

Authors:  P T Beernink; D A Caugant; J A Welsch; O Koeberling; D M Granoff
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

10.  Meningococcal genetic variation mechanisms viewed through comparative analysis of serogroup C strain FAM18.

Authors:  Stephen D Bentley; George S Vernikos; Lori A S Snyder; Carol Churcher; Claire Arrowsmith; Tracey Chillingworth; Ann Cronin; Paul H Davis; Nancy E Holroyd; Kay Jagels; Mark Maddison; Sharon Moule; Ester Rabbinowitsch; Sarah Sharp; Louise Unwin; Sally Whitehead; Michael A Quail; Mark Achtman; Bart Barrell; Nigel J Saunders; Julian Parkhill
Journal:  PLoS Genet       Date:  2006-12-21       Impact factor: 5.917

View more
  35 in total

1.  Effect of factor H-binding protein sequence variation on factor H binding and survival of Neisseria meningitidis in human blood.

Authors:  Kathleen Y Dunphy; Peter T Beernink; Barbara Brogioni; Dan M Granoff
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

2.  A meningococcal vaccine antigen engineered to increase thermal stability and stabilize protective epitopes.

Authors:  Monica Konar; Rolando Pajon; Peter T Beernink
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-16       Impact factor: 11.205

3.  A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccines.

Authors:  Oliver Koeberling; Isabel Delany; Dan M Granoff
Journal:  Clin Vaccine Immunol       Date:  2011-03-02

4.  Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeys.

Authors:  Oliver Koeberling; Anja Seubert; George Santos; Annalisa Colaprico; Mildred Ugozzoli; John Donnelly; Dan M Granoff
Journal:  Vaccine       Date:  2011-05-13       Impact factor: 3.641

5.  Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates.

Authors:  Jane W Marsh; Kathleen A Shutt; Rolando Pajon; Mary M Tulenko; Stephen Liu; Rosemary A Hollick; Julia A Kiehlbauch; Thomas A Clark; David S Stephens; Kathryn E Arnold; Robert A Myers; Leonard W Mayer; Lee H Harrison
Journal:  Vaccine       Date:  2011-06-24       Impact factor: 3.641

Review 6.  Review of meningococcal group B vaccines.

Authors:  Dan M Granoff
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

7.  Design of meningococcal factor H binding protein mutant vaccines that do not bind human complement factor H.

Authors:  Rolando Pajon; Peter T Beernink; Dan M Granoff
Journal:  Infect Immun       Date:  2012-05-21       Impact factor: 3.441

8.  Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding.

Authors:  Dan M Granoff; Serena Giuntini; Flor A Gowans; Eduardo Lujan; Kelsey Sharkey; Peter T Beernink
Journal:  JCI Insight       Date:  2016-09-08

Review 9.  The discovery and development of a novel vaccine to protect against Neisseria meningitidis Serogroup B Disease.

Authors:  Gary W Zlotnick; Thomas R Jones; Paul Liberator; Li Hao; Shannon Harris; Lisa K McNeil; Duzhang Zhu; John Perez; Joseph Eiden; Kathrin U Jansen; Annaliesa S Anderson
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

10.  Mapping genetic variants in the CFH gene for association with leprosy in Han Chinese.

Authors:  D-F Zhang; D Wang; Y-Y Li; Y-G Yao
Journal:  Genes Immun       Date:  2014-07-17       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.